Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,591 | 106,399 | 112,785 | 111,022 | 119,942 |
| TOTAL | $96,290 | $107,354 | $113,145 | $111,816 | $120,784 |
| Non-Current Assets | |||||
| PPE Net | 3,465 | 3,418 | 3,292 | 3,461 | 2,839 |
| Other Non-Current Assets | 143 | 143 | 143 | 143 | 143 |
| TOTAL | $3,608 | $3,561 | $3,435 | $3,604 | $2,982 |
| Total Assets | $99,898 | $110,914 | $116,579 | $115,420 | $123,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 580 | N/A | N/A | 2,389 | 2,330 |
| Accounts payable and accrued liabilities | 2,528 | 3,471 | 1,963 | 2,855 | 2,883 |
| Accrued Expenses | 3,639 | 3,214 | 2,290 | 1,520 | 1,358 |
| TOTAL | $6,746 | $6,685 | $4,254 | $6,764 | $6,571 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,506 | 14,953 | 14,818 | 1,900 | 2,472 |
| TOTAL | $14,506 | $14,953 | $14,818 | $1,900 | $2,472 |
| Total Liabilities | $21,251 | $21,638 | $19,071 | $8,664 | $9,043 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,541 | 1,450 | 1,446 | 1,445 | 1,441 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -113,259 | -101,075 | -91,560 | -80,801 | -71,424 |
| TOTAL | $78,647 | $89,277 | $97,508 | $106,756 | $114,723 |
| Total Liabilities And Equity | $99,898 | $110,915 | $116,579 | $115,420 | $123,766 |